by alfie | Jan 5, 2024 | news and press
< Back to Sanius content AI platform Sanius Health and primary care provider Modality Partnership announce £225m deal Sanius Health has announced a deal valued at £225 million which will see its data, research and personalised health patient AI platform leveraged...
by alfie | Dec 15, 2023 | study and resources
SICKLE CELL DISEASE Real-Time Vaccination Impacts in Sickle Cell Disease: A Real-World Patient Case Study for Influenza and Covid-19 Vaccination Annual Academy of Sickle Cell and Thalassaemia Conference, ASCAT (2022) Areas of interest /Real-world vaccination impacts...
by alfie | Dec 15, 2023 | study and resources
SICKLE CELL DISEASE Live Outcomes and Biometric Monitoring: Potential Implications For Patient Quality of Life in Sickle Cell Disease 17th Annual Sickle Cell and Thalassaemia Conference (2022) Areas of interest /Approaches to QoL assessment & their impact...
by alfie | Dec 15, 2023 | study and resources
SICKLE CELL DISEASE Real-World PROs and Wearable Metric Correlations: Remote Daily Monitoring for Exploration of Quality of Life in Sickle Cell Disease 17th Annual Sickle Cell and Thalassaemia Conference (2022) Areas of interest /Live disease baseline characterisation...
by alfie | Dec 15, 2023 | study and resources
SICKLE CELL DISEASE Using Wearables and Web-Based Self-Reporting to Explore Deep Sleep and PRO correlations in Sickle Cell Disease 63rd Annual Meeting, British Society of Haematology (2023) Areas of interest /Impact of real-time sleep metrics on QoL Biomarkers...